The Market Reports

Index

1 Study Coverage
1.1 Mesalamine Product Introduction
1.2 Market by Type
1.2.1 Global Mesalamine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Purity ≥ 97%
1.2.3 Purity ≥ 98%
1.2.4 Purity ≥ 99%
1.3 Market by Application
1.3.1 Global Mesalamine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Mesalazine Tablets
1.3.3 Mesalazine Capsules
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Mesalamine Sales Estimates and Forecasts 2017-2028
2.2 Global Mesalamine Revenue Estimates and Forecasts 2017-2028
2.3 Global Mesalamine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Mesalamine Sales by Region
2.4.1 Global Mesalamine Sales by Region (2017-2022)
2.4.2 Global Sales Mesalamine by Region (2023-2028)
2.5 Global Mesalamine Revenue by Region
2.5.1 Global Mesalamine Revenue by Region (2017-2022)
2.5.2 Global Mesalamine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Mesalamine Sales by Manufacturers
3.1.1 Global Top Mesalamine Manufacturers by Sales (2017-2022)
3.1.2 Global Mesalamine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Mesalamine in 2021
3.2 Global Mesalamine Revenue by Manufacturers
3.2.1 Global Mesalamine Revenue by Manufacturers (2017-2022)
3.2.2 Global Mesalamine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Mesalamine Revenue in 2021
3.3 Global Mesalamine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Mesalamine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Mesalamine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Mesalamine Sales by Type
4.1.1 Global Mesalamine Historical Sales by Type (2017-2022)
4.1.2 Global Mesalamine Forecasted Sales by Type (2023-2028)
4.1.3 Global Mesalamine Sales Market Share by Type (2017-2028)
4.2 Global Mesalamine Revenue by Type
4.2.1 Global Mesalamine Historical Revenue by Type (2017-2022)
4.2.2 Global Mesalamine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Mesalamine Revenue Market Share by Type (2017-2028)
4.3 Global Mesalamine Price by Type
4.3.1 Global Mesalamine Price by Type (2017-2022)
4.3.2 Global Mesalamine Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Mesalamine Sales by Application
5.1.1 Global Mesalamine Historical Sales by Application (2017-2022)
5.1.2 Global Mesalamine Forecasted Sales by Application (2023-2028)
5.1.3 Global Mesalamine Sales Market Share by Application (2017-2028)
5.2 Global Mesalamine Revenue by Application
5.2.1 Global Mesalamine Historical Revenue by Application (2017-2022)
5.2.2 Global Mesalamine Forecasted Revenue by Application (2023-2028)
5.2.3 Global Mesalamine Revenue Market Share by Application (2017-2028)
5.3 Global Mesalamine Price by Application
5.3.1 Global Mesalamine Price by Application (2017-2022)
5.3.2 Global Mesalamine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Mesalamine Market Size by Type
6.1.1 North America Mesalamine Sales by Type (2017-2028)
6.1.2 North America Mesalamine Revenue by Type (2017-2028)
6.2 North America Mesalamine Market Size by Application
6.2.1 North America Mesalamine Sales by Application (2017-2028)
6.2.2 North America Mesalamine Revenue by Application (2017-2028)
6.3 North America Mesalamine Market Size by Country
6.3.1 North America Mesalamine Sales by Country (2017-2028)
6.3.2 North America Mesalamine Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Mesalamine Market Size by Type
7.1.1 Europe Mesalamine Sales by Type (2017-2028)
7.1.2 Europe Mesalamine Revenue by Type (2017-2028)
7.2 Europe Mesalamine Market Size by Application
7.2.1 Europe Mesalamine Sales by Application (2017-2028)
7.2.2 Europe Mesalamine Revenue by Application (2017-2028)
7.3 Europe Mesalamine Market Size by Country
7.3.1 Europe Mesalamine Sales by Country (2017-2028)
7.3.2 Europe Mesalamine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Mesalamine Market Size by Type
8.1.1 Asia Pacific Mesalamine Sales by Type (2017-2028)
8.1.2 Asia Pacific Mesalamine Revenue by Type (2017-2028)
8.2 Asia Pacific Mesalamine Market Size by Application
8.2.1 Asia Pacific Mesalamine Sales by Application (2017-2028)
8.2.2 Asia Pacific Mesalamine Revenue by Application (2017-2028)
8.3 Asia Pacific Mesalamine Market Size by Region
8.3.1 Asia Pacific Mesalamine Sales by Region (2017-2028)
8.3.2 Asia Pacific Mesalamine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Mesalamine Market Size by Type
9.1.1 Latin America Mesalamine Sales by Type (2017-2028)
9.1.2 Latin America Mesalamine Revenue by Type (2017-2028)
9.2 Latin America Mesalamine Market Size by Application
9.2.1 Latin America Mesalamine Sales by Application (2017-2028)
9.2.2 Latin America Mesalamine Revenue by Application (2017-2028)
9.3 Latin America Mesalamine Market Size by Country
9.3.1 Latin America Mesalamine Sales by Country (2017-2028)
9.3.2 Latin America Mesalamine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Mesalamine Market Size by Type
10.1.1 Middle East and Africa Mesalamine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Mesalamine Revenue by Type (2017-2028)
10.2 Middle East and Africa Mesalamine Market Size by Application
10.2.1 Middle East and Africa Mesalamine Sales by Application (2017-2028)
10.2.2 Middle East and Africa Mesalamine Revenue by Application (2017-2028)
10.3 Middle East and Africa Mesalamine Market Size by Country
10.3.1 Middle East and Africa Mesalamine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Mesalamine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Syntese A/S
11.1.1 Syntese A/S Corporation Information
11.1.2 Syntese A/S Overview
11.1.3 Syntese A/S Mesalamine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Syntese A/S Mesalamine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Syntese A/S Recent Developments
11.2 Divis Laboratories
11.2.1 Divis Laboratories Corporation Information
11.2.2 Divis Laboratories Overview
11.2.3 Divis Laboratories Mesalamine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Divis Laboratories Mesalamine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Divis Laboratories Recent Developments
11.3 Cambrex Corporation
11.3.1 Cambrex Corporation Corporation Information
11.3.2 Cambrex Corporation Overview
11.3.3 Cambrex Corporation Mesalamine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Cambrex Corporation Mesalamine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Cambrex Corporation Recent Developments
11.4 Ipca Laboratories
11.4.1 Ipca Laboratories Corporation Information
11.4.2 Ipca Laboratories Overview
11.4.3 Ipca Laboratories Mesalamine Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Ipca Laboratories Mesalamine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Ipca Laboratories Recent Developments
11.5 Hangzhou Brother
11.5.1 Hangzhou Brother Corporation Information
11.5.2 Hangzhou Brother Overview
11.5.3 Hangzhou Brother Mesalamine Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Hangzhou Brother Mesalamine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Hangzhou Brother Recent Developments
11.6 PharmaZell
11.6.1 PharmaZell Corporation Information
11.6.2 PharmaZell Overview
11.6.3 PharmaZell Mesalamine Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 PharmaZell Mesalamine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 PharmaZell Recent Developments
11.7 Lianyungang Fengheng Biopharm
11.7.1 Lianyungang Fengheng Biopharm Corporation Information
11.7.2 Lianyungang Fengheng Biopharm Overview
11.7.3 Lianyungang Fengheng Biopharm Mesalamine Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Lianyungang Fengheng Biopharm Mesalamine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Lianyungang Fengheng Biopharm Recent Developments
11.8 Lasa Loboratory
11.8.1 Lasa Loboratory Corporation Information
11.8.2 Lasa Loboratory Overview
11.8.3 Lasa Loboratory Mesalamine Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Lasa Loboratory Mesalamine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Lasa Loboratory Recent Developments
11.9 Erregierre SpA
11.9.1 Erregierre SpA Corporation Information
11.9.2 Erregierre SpA Overview
11.9.3 Erregierre SpA Mesalamine Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Erregierre SpA Mesalamine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Erregierre SpA Recent Developments
11.10 Corden Pharma Bergamo
11.10.1 Corden Pharma Bergamo Corporation Information
11.10.2 Corden Pharma Bergamo Overview
11.10.3 Corden Pharma Bergamo Mesalamine Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Corden Pharma Bergamo Mesalamine Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Corden Pharma Bergamo Recent Developments
11.11 CTX Lifescience
11.11.1 CTX Lifescience Corporation Information
11.11.2 CTX Lifescience Overview
11.11.3 CTX Lifescience Mesalamine Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 CTX Lifescience Mesalamine Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 CTX Lifescience Recent Developments
11.12 Ishita Active Pharma Ingredients
11.12.1 Ishita Active Pharma Ingredients Corporation Information
11.12.2 Ishita Active Pharma Ingredients Overview
11.12.3 Ishita Active Pharma Ingredients Mesalamine Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Ishita Active Pharma Ingredients Mesalamine Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Ishita Active Pharma Ingredients Recent Developments
11.13 YC Biotech (Jiangsu)
11.13.1 YC Biotech (Jiangsu) Corporation Information
11.13.2 YC Biotech (Jiangsu) Overview
11.13.3 YC Biotech (Jiangsu) Mesalamine Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 YC Biotech (Jiangsu) Mesalamine Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 YC Biotech (Jiangsu) Recent Developments
11.14 Xinxiang Tianfeng Fine Chemical
11.14.1 Xinxiang Tianfeng Fine Chemical Corporation Information
11.14.2 Xinxiang Tianfeng Fine Chemical Overview
11.14.3 Xinxiang Tianfeng Fine Chemical Mesalamine Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Xinxiang Tianfeng Fine Chemical Mesalamine Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Xinxiang Tianfeng Fine Chemical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Mesalamine Industry Chain Analysis
12.2 Mesalamine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Mesalamine Production Mode & Process
12.4 Mesalamine Sales and Marketing
12.4.1 Mesalamine Sales Channels
12.4.2 Mesalamine Distributors
12.5 Mesalamine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Mesalamine Industry Trends
13.2 Mesalamine Market Drivers
13.3 Mesalamine Market Challenges
13.4 Mesalamine Market Restraints
14 Key Findings in The Global Mesalamine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables

List of Tables
Table 1. Global Mesalamine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Purity ≥ 97%
Table 3. Major Manufacturers of Purity ≥ 98%
Table 4. Major Manufacturers of Purity ≥ 99%
Table 5. Global Mesalamine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Mesalamine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Mesalamine Sales by Region (2017-2022) & (MT)
Table 8. Global Mesalamine Sales Market Share by Region (2017-2022)
Table 9. Global Mesalamine Sales by Region (2023-2028) & (MT)
Table 10. Global Mesalamine Sales Market Share by Region (2023-2028)
Table 11. Global Mesalamine Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Mesalamine Revenue Market Share by Region (2017-2022)
Table 13. Global Mesalamine Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global Mesalamine Revenue Market Share by Region (2023-2028)
Table 15. Global Mesalamine Sales by Manufacturers (2017-2022) & (MT)
Table 16. Global Mesalamine Sales Share by Manufacturers (2017-2022)
Table 17. Global Mesalamine Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global Mesalamine Revenue Share by Manufacturers (2017-2022)
Table 19. Mesalamine Price by Manufacturers (2017-2022) &(USD/Kg)
Table 20. Global Mesalamine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Mesalamine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mesalamine as of 2021)
Table 22. Mesalamine Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Mesalamine Product Offered
Table 24. Date of Manufacturers Enter into Mesalamine Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Mesalamine Sales by Type (2017-2022) & (MT)
Table 27. Global Mesalamine Sales by Type (2023-2028) & (MT)
Table 28. Global Mesalamine Sales Share by Type (2017-2022)
Table 29. Global Mesalamine Sales Share by Type (2023-2028)
Table 30. Global Mesalamine Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global Mesalamine Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global Mesalamine Revenue Share by Type (2017-2022)
Table 33. Global Mesalamine Revenue Share by Type (2023-2028)
Table 34. Mesalamine Price by Type (2017-2022) & (USD/Kg)
Table 35. Global Mesalamine Price Forecast by Type (2023-2028) & (USD/Kg)
Table 36. Global Mesalamine Sales by Application (2017-2022) & (MT)
Table 37. Global Mesalamine Sales by Application (2023-2028) & (MT)
Table 38. Global Mesalamine Sales Share by Application (2017-2022)
Table 39. Global Mesalamine Sales Share by Application (2023-2028)
Table 40. Global Mesalamine Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global Mesalamine Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global Mesalamine Revenue Share by Application (2017-2022)
Table 43. Global Mesalamine Revenue Share by Application (2023-2028)
Table 44. Mesalamine Price by Application (2017-2022) & (USD/Kg)
Table 45. Global Mesalamine Price Forecast by Application (2023-2028) & (USD/Kg)
Table 46. North America Mesalamine Sales by Type (2017-2022) & (MT)
Table 47. North America Mesalamine Sales by Type (2023-2028) & (MT)
Table 48. North America Mesalamine Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America Mesalamine Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America Mesalamine Sales by Application (2017-2022) & (MT)
Table 51. North America Mesalamine Sales by Application (2023-2028) & (MT)
Table 52. North America Mesalamine Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America Mesalamine Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America Mesalamine Sales by Country (2017-2022) & (MT)
Table 55. North America Mesalamine Sales by Country (2023-2028) & (MT)
Table 56. North America Mesalamine Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America Mesalamine Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe Mesalamine Sales by Type (2017-2022) & (MT)
Table 59. Europe Mesalamine Sales by Type (2023-2028) & (MT)
Table 60. Europe Mesalamine Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe Mesalamine Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe Mesalamine Sales by Application (2017-2022) & (MT)
Table 63. Europe Mesalamine Sales by Application (2023-2028) & (MT)
Table 64. Europe Mesalamine Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe Mesalamine Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe Mesalamine Sales by Country (2017-2022) & (MT)
Table 67. Europe Mesalamine Sales by Country (2023-2028) & (MT)
Table 68. Europe Mesalamine Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe Mesalamine Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific Mesalamine Sales by Type (2017-2022) & (MT)
Table 71. Asia Pacific Mesalamine Sales by Type (2023-2028) & (MT)
Table 72. Asia Pacific Mesalamine Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific Mesalamine Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific Mesalamine Sales by Application (2017-2022) & (MT)
Table 75. Asia Pacific Mesalamine Sales by Application (2023-2028) & (MT)
Table 76. Asia Pacific Mesalamine Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific Mesalamine Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific Mesalamine Sales by Region (2017-2022) & (MT)
Table 79. Asia Pacific Mesalamine Sales by Region (2023-2028) & (MT)
Table 80. Asia Pacific Mesalamine Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific Mesalamine Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America Mesalamine Sales by Type (2017-2022) & (MT)
Table 83. Latin America Mesalamine Sales by Type (2023-2028) & (MT)
Table 84. Latin America Mesalamine Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America Mesalamine Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America Mesalamine Sales by Application (2017-2022) & (MT)
Table 87. Latin America Mesalamine Sales by Application (2023-2028) & (MT)
Table 88. Latin America Mesalamine Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America Mesalamine Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America Mesalamine Sales by Country (2017-2022) & (MT)
Table 91. Latin America Mesalamine Sales by Country (2023-2028) & (MT)
Table 92. Latin America Mesalamine Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America Mesalamine Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa Mesalamine Sales by Type (2017-2022) & (MT)
Table 95. Middle East and Africa Mesalamine Sales by Type (2023-2028) & (MT)
Table 96. Middle East and Africa Mesalamine Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa Mesalamine Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Mesalamine Sales by Application (2017-2022) & (MT)
Table 99. Middle East and Africa Mesalamine Sales by Application (2023-2028) & (MT)
Table 100. Middle East and Africa Mesalamine Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Mesalamine Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Mesalamine Sales by Country (2017-2022) & (MT)
Table 103. Middle East and Africa Mesalamine Sales by Country (2023-2028) & (MT)
Table 104. Middle East and Africa Mesalamine Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Mesalamine Revenue by Country (2023-2028) & (US$ Million)
Table 106. Syntese A/S Corporation Information
Table 107. Syntese A/S Description and Major Businesses
Table 108. Syntese A/S Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 109. Syntese A/S Mesalamine Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. Syntese A/S Recent Developments
Table 111. Divis Laboratories Corporation Information
Table 112. Divis Laboratories Description and Major Businesses
Table 113. Divis Laboratories Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 114. Divis Laboratories Mesalamine Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Divis Laboratories Recent Developments
Table 116. Cambrex Corporation Corporation Information
Table 117. Cambrex Corporation Description and Major Businesses
Table 118. Cambrex Corporation Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 119. Cambrex Corporation Mesalamine Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Cambrex Corporation Recent Developments
Table 121. Ipca Laboratories Corporation Information
Table 122. Ipca Laboratories Description and Major Businesses
Table 123. Ipca Laboratories Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 124. Ipca Laboratories Mesalamine Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Ipca Laboratories Recent Developments
Table 126. Hangzhou Brother Corporation Information
Table 127. Hangzhou Brother Description and Major Businesses
Table 128. Hangzhou Brother Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 129. Hangzhou Brother Mesalamine Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Hangzhou Brother Recent Developments
Table 131. PharmaZell Corporation Information
Table 132. PharmaZell Description and Major Businesses
Table 133. PharmaZell Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 134. PharmaZell Mesalamine Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. PharmaZell Recent Developments
Table 136. Lianyungang Fengheng Biopharm Corporation Information
Table 137. Lianyungang Fengheng Biopharm Description and Major Businesses
Table 138. Lianyungang Fengheng Biopharm Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 139. Lianyungang Fengheng Biopharm Mesalamine Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Lianyungang Fengheng Biopharm Recent Developments
Table 141. Lasa Loboratory Corporation Information
Table 142. Lasa Loboratory Description and Major Businesses
Table 143. Lasa Loboratory Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 144. Lasa Loboratory Mesalamine Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. Lasa Loboratory Recent Developments
Table 146. Erregierre SpA Corporation Information
Table 147. Erregierre SpA Description and Major Businesses
Table 148. Erregierre SpA Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 149. Erregierre SpA Mesalamine Product Model Numbers, Pictures, Descriptions and Specifications
Table 150. Erregierre SpA Recent Developments
Table 151. Corden Pharma Bergamo Corporation Information
Table 152. Corden Pharma Bergamo Description and Major Businesses
Table 153. Corden Pharma Bergamo Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 154. Corden Pharma Bergamo Mesalamine Product Model Numbers, Pictures, Descriptions and Specifications
Table 155. Corden Pharma Bergamo Recent Developments
Table 156. CTX Lifescience Corporation Information
Table 157. CTX Lifescience Description and Major Businesses
Table 158. CTX Lifescience Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 159. CTX Lifescience Mesalamine Product Model Numbers, Pictures, Descriptions and Specifications
Table 160. CTX Lifescience Recent Developments
Table 161. Ishita Active Pharma Ingredients Corporation Information
Table 162. Ishita Active Pharma Ingredients Description and Major Businesses
Table 163. Ishita Active Pharma Ingredients Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 164. Ishita Active Pharma Ingredients Mesalamine Product Model Numbers, Pictures, Descriptions and Specifications
Table 165. Ishita Active Pharma Ingredients Recent Developments
Table 166. YC Biotech (Jiangsu) Corporation Information
Table 167. YC Biotech (Jiangsu) Description and Major Businesses
Table 168. YC Biotech (Jiangsu) Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 169. YC Biotech (Jiangsu) Mesalamine Product Model Numbers, Pictures, Descriptions and Specifications
Table 170. YC Biotech (Jiangsu) Recent Developments
Table 171. Xinxiang Tianfeng Fine Chemical Corporation Information
Table 172. Xinxiang Tianfeng Fine Chemical Description and Major Businesses
Table 173. Xinxiang Tianfeng Fine Chemical Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 174. Xinxiang Tianfeng Fine Chemical Mesalamine Product Model Numbers, Pictures, Descriptions and Specifications
Table 175. Xinxiang Tianfeng Fine Chemical Recent Developments
Table 176. Key Raw Materials Lists
Table 177. Raw Materials Key Suppliers Lists
Table 178. Mesalamine Distributors List
Table 179. Mesalamine Customers List
Table 180. Mesalamine Market Trends
Table 181. Mesalamine Market Drivers
Table 182. Mesalamine Market Challenges
Table 183. Mesalamine Market Restraints
Table 184. Research Programs/Design for This Report
Table 185. Key Data Information from Secondary Sources
Table 186. Key Data Information from Primary Sources
List of Figures
Figure 1. Mesalamine Product Picture
Figure 3. Global Mesalamine Market Share by Type in 2021 & 2028
Figure 3. Purity ≥ 97% Product Picture
Figure 4. Purity ≥ 98% Product Picture
Figure 5. Purity ≥ 99% Product Picture
Figure 6. Global Mesalamine Market Share by Application in 2021 & 2028
Figure 7. Mesalazine Tablets
Figure 8. Mesalazine Capsules
Figure 9. Others
Figure 10. Mesalamine Report Years Considered
Figure 11. Global Mesalamine Sales 2017-2028 (MT)
Figure 12. Global Mesalamine Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Mesalamine Revenue 2017-2028 (US$ Million)
Figure 14. Global Mesalamine Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global Mesalamine Sales Market Share by Region (2017-2022)
Figure 16. Global Mesalamine Sales Market Share by Region (2023-2028)
Figure 17. North America Mesalamine Sales YoY (2017-2028) & (MT)
Figure 18. North America Mesalamine Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Europe Mesalamine Sales YoY (2017-2028) & (MT)
Figure 20. Europe Mesalamine Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Asia-Pacific Mesalamine Sales YoY (2017-2028) & (MT)
Figure 22. Asia-Pacific Mesalamine Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Latin America Mesalamine Sales YoY (2017-2028) & (MT)
Figure 24. Latin America Mesalamine Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Middle East & Africa Mesalamine Sales YoY (2017-2028) & (MT)
Figure 26. Middle East & Africa Mesalamine Revenue YoY (2017-2028) & (US$ Million)
Figure 27. The Mesalamine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 28. The Top 5 and 10 Largest Manufacturers of Mesalamine in the World: Market Share by Mesalamine Revenue in 2021
Figure 29. Global Mesalamine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 30. Global Mesalamine Sales Market Share by Type (2017-2028)
Figure 31. Global Mesalamine Revenue Market Share by Type (2017-2028)
Figure 32. Global Mesalamine Sales Market Share by Application (2017-2028)
Figure 33. Global Mesalamine Revenue Market Share by Application (2017-2028)
Figure 34. North America Mesalamine Sales Market Share by Type (2017-2028)
Figure 35. North America Mesalamine Revenue Market Share by Type (2017-2028)
Figure 36. North America Mesalamine Sales Market Share by Application (2017-2028)
Figure 37. North America Mesalamine Revenue Market Share by Application (2017-2028)
Figure 38. North America Mesalamine Sales Share by Country (2017-2028)
Figure 39. North America Mesalamine Revenue Share by Country (2017-2028)
Figure 40. U.S. Mesalamine Revenue (2017-2028) & (US$ Million)
Figure 41. Canada Mesalamine Revenue (2017-2028) & (US$ Million)
Figure 42. Europe Mesalamine Sales Market Share by Type (2017-2028)
Figure 43. Europe Mesalamine Revenue Market Share by Type (2017-2028)
Figure 44. Europe Mesalamine Sales Market Share by Application (2017-2028)
Figure 45. Europe Mesalamine Revenue Market Share by Application (2017-2028)
Figure 46. Europe Mesalamine Sales Share by Country (2017-2028)
Figure 47. Europe Mesalamine Revenue Share by Country (2017-2028)
Figure 48. Germany Mesalamine Revenue (2017-2028) & (US$ Million)
Figure 49. France Mesalamine Revenue (2017-2028) & (US$ Million)
Figure 50. U.K. Mesalamine Revenue (2017-2028) & (US$ Million)
Figure 51. Italy Mesalamine Revenue (2017-2028) & (US$ Million)
Figure 52. Russia Mesalamine Revenue (2017-2028) & (US$ Million)
Figure 53. Asia Pacific Mesalamine Sales Market Share by Type (2017-2028)
Figure 54. Asia Pacific Mesalamine Revenue Market Share by Type (2017-2028)
Figure 55. Asia Pacific Mesalamine Sales Market Share by Application (2017-2028)
Figure 56. Asia Pacific Mesalamine Revenue Market Share by Application (2017-2028)
Figure 57. Asia Pacific Mesalamine Sales Share by Region (2017-2028)
Figure 58. Asia Pacific Mesalamine Revenue Share by Region (2017-2028)
Figure 59. China Mesalamine Revenue (2017-2028) & (US$ Million)
Figure 60. Japan Mesalamine Revenue (2017-2028) & (US$ Million)
Figure 61. South Korea Mesalamine Revenue (2017-2028) & (US$ Million)
Figure 62. India Mesalamine Revenue (2017-2028) & (US$ Million)
Figure 63. Australia Mesalamine Revenue (2017-2028) & (US$ Million)
Figure 64. Taiwan Mesalamine Revenue (2017-2028) & (US$ Million)
Figure 65. Indonesia Mesalamine Revenue (2017-2028) & (US$ Million)
Figure 66. Thailand Mesalamine Revenue (2017-2028) & (US$ Million)
Figure 67. Malaysia Mesalamine Revenue (2017-2028) & (US$ Million)
Figure 68. Philippines Mesalamine Revenue (2017-2028) & (US$ Million)
Figure 69. Latin America Mesalamine Sales Market Share by Type (2017-2028)
Figure 70. Latin America Mesalamine Revenue Market Share by Type (2017-2028)
Figure 71. Latin America Mesalamine Sales Market Share by Application (2017-2028)
Figure 72. Latin America Mesalamine Revenue Market Share by Application (2017-2028)
Figure 73. Latin America Mesalamine Sales Share by Country (2017-2028)
Figure 74. Latin America Mesalamine Revenue Share by Country (2017-2028)
Figure 75. Mexico Mesalamine Revenue (2017-2028) & (US$ Million)
Figure 76. Brazil Mesalamine Revenue (2017-2028) & (US$ Million)
Figure 77. Argentina Mesalamine Revenue (2017-2028) & (US$ Million)
Figure 78. Middle East and Africa Mesalamine Sales Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Mesalamine Revenue Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Mesalamine Sales Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Mesalamine Revenue Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Mesalamine Sales Share by Country (2017-2028)
Figure 83. Middle East and Africa Mesalamine Revenue Share by Country (2017-2028)
Figure 84. Turkey Mesalamine Revenue (2017-2028) & (US$ Million)
Figure 85. Saudi Arabia Mesalamine Revenue (2017-2028) & (US$ Million)
Figure 86. UAE Mesalamine Revenue (2017-2028) & (US$ Million)
Figure 87. Mesalamine Value Chain
Figure 88. Mesalamine Production Process
Figure 89. Channels of Distribution
Figure 90. Distributors Profiles
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed